Skip to content
Home/Companies/HealthTech/Sympatient
Sympatient

Sympatient

HealthTech·Germany·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Sympatient?

Sympatient is currently owned by IFB Innovationsstarter through Innovationsstarter Fonds Hamburg II (2017 vintage), since 2020.

Hand-verified · updated 2026-07-07

IFB Innovationsstarter
Investor
IFB Innovationsstarter
Innovationsstarter Fonds Hamburg II · 2017 · VC

Key facts

HQGermany
SectorHealthTech
StatusActive
Websitesympatient.com

More from Innovationsstarter Fonds Hamburg II

Other portfolio companies in the same fund.

Bluu Seafood
Active
BiotechGermany· 2020
LignoPure
LignoPure
Active
IndustrialsGermany· 2019
MindPeak
Active
SoftwareGermany· 2019
Resourcify
Active
SoftwareGermany· 2018
HQLabs
Exited 2022
SoftwareGermany· 2017
to
KSK Diagnostics
Active
MedTechGermany· 2017

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
agilon health
agilon health
Active
CD&RUS
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Track Sympatient

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Sympatient?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Sympatient.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue